A very interesting and fruitful meeting was hosted by the European Union Drugs Agency (EUDA) today in Lisbon, Portugal. The objective of the consultation meeting is to explore ways to strengthen cooperation, share best practices and promote mutual understanding between EUDA and civil society organisations in order to ‘attain maximum efficiency in monitoring, assessing and responding to the drugs phenomenon’ (Article 5(7) of Regulation (EU) 2023/1322).
The European Union Regulation (2023/1322) establishing the European Union Drugs Agency (EUDA) calls on the EUDA to intensify cooperation and collaboration with civil society organisations (CSOs), including organisations of people who use drugs and communities affected by the consumption and sale of drugs or drug-related crime. This should involve consultations, information exchange and knowledge sharing. Recognising the value of these potential developments, the EUDA convened the consultation meeting in the margins of the Lisbon 2024 Addiction Conference.
More than 60 participants came not only from EUDA and civil society organisations from different corners of Europe and covering different thematic areas of drug policy but also from governmental institutions, academia and others. They provided invaluable input for the formulation of a roadmap outlining the regular and systematic cooperation with civil society organisations.
These issues addressed in the sessions dealt with the path of cooperation, the added value and the range of possible cooperation mechanisms. A panel discussion shed light on the concept of affected communities by the consumption and sale of drugs or drug related crime. The final panel discussion examined future perspectives.
DPNSEE Executive Director Milutin Milošević, who was one of the EU Civil Society Forum on Drugs representatives at the meeting, proposed two point for cooperation between EUDA and civil society:
- Working together of supporting candidate countries in their EU accession process, particularly in adjusting the aquis in the area of drugs which are almost exclusively directed to law anforcement, with just a small reference on health and no single letter about human rights of people who use drugs;
- Facilitating better cooperation between national institutions and civil society, which are not involved in strategic planning (that is usually missing in the candidate countries) and reporting.
